Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Leukemia, Promyelocytic, Acute 5Thrombocytopenia 2Pathologic Complete Response 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Pancreatic Neoplasms 2Neoplasm Metastasis 2Melanoma 2Lung Neoplasms 2Leukemia 2Hematologic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma 1Primary Myelofibrosis 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Oligometastatic Disease 1Oligodendroglioma 1Neoplasms 1Myelodysplastic Syndromes 1Multiple Myeloma 1Leukemia, Myeloid, Acute 1Leiomyosarcoma 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Hematologic Diseases 1Head and Neck Neoplasms 1HER2 Negative Breast Cancer 1Glioma 1

Interventions

Doxorubicin 6Specimen Handling 5Radiotherapy 3Radiation 3Nivolumab 3Magnetic Resonance Spectroscopy 3Gemcitabine 3Biopsy 3pembrolizumab 2liposomal doxorubicin 2eribulin 2Ifosfamide 2toripalimab 1talimogene laherparepvec 1rucaparib 1ribociclib 1regorafenib 1peposertib 1pazopanib 1olaratumab 1olaparib 1lenvatinib 1futibatinib 1durvalumab 1dinutuximab 1cemiplimab 1cediranib 1cabozantinib 1avelumab 1anlotinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leiomyosarcoma × Tretinoin × 1 year × Clear all
NCT06528769 2025-09-30

Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting
16 enrolled
Sarcoma

Leiomyosarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡